Abstract:Background: Candida albicans ( C. albicans) is the most common opportunistic fungal species in the oral cavity. The emergence of drug resistance of C. albicans has necessitated the development of novel anti -fungal agents.Objectives: This study evaluated the antifungal activity of a previously developed antimicrobial small molecule, namely II-6s, and explored its potential synergism with fluconazole against C. albicans and the underlying mechanisms.Methods: The antifungal effects of II-6s against C. albicans were evaluated with microdilution and time -killing assays. Synergism of II-6s with fluconazole was determined by calculating the fractional in-hibitory concentration index (FICI). The effects of II-6s on efflux pump, mitochondrial function and energy metabolism were examined to investigate the underlying mechanism of synergism. The antifungal mech-anism of II-6s against C. albicans was further explored with RNA-seq and validated with specific mutant strains.Results: II-6s exhibited a fungicidal effect against C. albicans with a minimum fungicidal concentration of 31.25 mu g/mL. II-6s also inhibited C. albicans biofilm with a sessile minimum inhibitory concentration at 500 mu g/mL. More importantly, II-6s showed a synergistic effect with fluconazole against a fluconazole-resistant strain of C. albicans, which expressed elevated levels of CDR1 (FICI < 0.5). II-6s inhibited the efflux pump activity of C. albicans. Consistently, II-6s inhibited energy metabolism of C. albicans by re-ducing the mitochondrial membrane potential and ATP generation, and inhibited utilisation of the non -fermentable carbon source. II-6s also inhibited the mitogen-activated protein kinase signal pathway, par-ticularly HOG1, which may explain its antifungal activity against C. albicans.Conclusion: The small molecule II-6s inhibits the growth of C. albicans by targeting HOG1. II-6s also synergises with fluconazole by inhibiting the drug efflux pump, representing a promising antifungal agent for the control of candidiasis.(c) 2023 Elsevier Ltd and International Society of Antimicrobial Chemotherapy. All rights reserved.

Synthesis and Synergistic Antifungal Effects of Monoketone Derivatives of Curcumin Against Fluconazole-Resistant Candida Spp.

Novel Potentially Antifungal Hybrids of 5-Flucytosine and Fluconazole: Design, Synthesis and Bioactive Evaluation.

Synergistic Antifungal Effects of Curcumin Derivatives As Fungal Biofilm Inhibitors with Fluconazole.

Discovery of Novel Thiosemicarbazides Containing 1,3,5-Triazines Derivatives as Potential Synergists against Fluconazole-Resistant Candida albicans

Synthesis and antifungal evaluation of novel triazole derivatives bearing a pyrazole-methoxyl moiety

Design,synthesis and evaluation of the compounds combined with fluconazole against drug resistant Candida albicans

Design, Synthesis, and Evaluation of Caffeic Acid Amides As Synergists to Sensitize Fluconazole-Resistant Candida Albicans to Fluconazole.

The Synthesis and Synergistic Antifungal Effects of Chalcones Against Drug Resistant Candida Albicans.

Antifungal Activities of Phenolic Compounds Against Candida Albicans and Their Structure-Activity Relationship

Antifungal Effects of Phytocompounds on Candida Species Alone and in Combination with Fluconazole.

Design, Synthesis, and SAR Study of 3-(Benzo[ D ][1,3]Dioxol-5-yl)- N -Benzylpropanamide As Novel Potent Synergists Against Fluconazole-Resistant Candida Albicans

Synergistic Effect of the Combination of Deferoxamine and Fluconazole in Vitro and in Vivo Against Fluconazole-Resistant Candida Spp.

Design, Synthesis, and SAR Study of 3-(Benzo[d][1,3]dioxo1-5-y1)-n-benzylpropanamide As Novel Potent Synergists Against Fluconazole-Resistant Candida Albicans

Synthesis, in Vitro Evaluation and Molecular Docking Studies of New Triazole Derivatives As Antifungal Agents.

Antifungal Activity of Minocycline and Azoles Against Fluconazole-Resistant Candida Species

Synergistic in Vitro Activity of Sodium Houttuyfonate with Fluconazole Against Clinical Candida Albicans Strains under Planktonic Growing Conditions

Small Molecule II-6s Synergises with Fluconazole Against Candida Albicans.

Diversity-oriented synthesis of pyrazoles derivatives from flavones and isoflavones leads to the discovery of promising reversal agents of fluconazole resistance in Candida albicans.

Derivatization of Berberine Based on Its Synergistic Antifungal Activity with Fluconazole Against Fluconazole-Resistant Candida Albicans

Synergistic Antifungal Effect of Fluconazole Combined with Licofelone Against Resistant Candida Albicans

Synthesis, Molecular Docking, and Biological Evaluation of Novel Triazole Derivatives as Antifungal Agents